CPhI Korea 2014 Scheduled for Sept. 2-3 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

CPhI Korea 2014 Scheduled for Sept. 2-3


CPhI Korea 2014 is scheduled to take place on Sept. 2-3 at the COEX in Seoul, South Korea. Co-organized by the Korean Pharmaceutical Traders Association, the event will co-locate with ICSE, to cover pharmaceutical supply chain sourcing and partnerships.

CPhI Korea and ICSE will provide pharmaceutical manufacturers access to global suppliers across various aspects of the pharmaceutical supply chain, including raw materials, machinery, packaging solutions and contracting services. Conference programs will offer insights from key government, industry, and academic opinion leaders.

UBM Live, the organizer of CPhI Korea, reports the value of the South Korean pharmaceutical market is expected to reach $24.3 billion in 2020 according to a MarketOptimizer.com report. Further solidifying South Korea as one of the largest pharmaceutical markets in Asia, the country’s Pharma 2020 vision is to commit $8.9 billion to drug development by 2020. CPhI Korea will grant key delegates and industry leaders from Japan, China, India and Hong Kong access to this growing market.

Source: CPhI Korea

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes

Click here